Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 92

1.

Human Cytomegalovirus-Infected Glioblastoma Cells Display Stem Cell-Like Phenotypes.

Liu C, Clark PA, Kuo JS, Kalejta RF.

mSphere. 2017 Jun 21;2(3). pii: e00137-17. doi: 10.1128/mSphere.00137-17. eCollection 2017 May-Jun.

2.

Cytomegalovirus infection induces a stem cell phenotype in human primary glioblastoma cells: prognostic significance and biological impact.

Fornara O, Bartek J Jr, Rahbar A, Odeberg J, Khan Z, Peredo I, Hamerlik P, Bartek J, Stragliotto G, Landázuri N, Söderberg-Nauclér C.

Cell Death Differ. 2016 Feb;23(2):261-9. doi: 10.1038/cdd.2015.91. Epub 2015 Jul 3.

3.

Significant association of multiple human cytomegalovirus genomic Loci with glioblastoma multiforme samples.

Ranganathan P, Clark PA, Kuo JS, Salamat MS, Kalejta RF.

J Virol. 2012 Jan;86(2):854-64. doi: 10.1128/JVI.06097-11. Epub 2011 Nov 16.

4.

Impact of human cytomegalovirus on glioblastoma cell viability and chemotherapy treatment.

Dos Santos CJ, Ferreira Castro FL, de Aguiar RB, Menezes IG, Santos AC, Paulus C, Nevels M, Carlan da Silva MC.

J Gen Virol. 2018 Sep;99(9):1274-1285. doi: 10.1099/jgv.0.001118. Epub 2018 Jul 27.

PMID:
30045780
5.

Human cytomegalovirus US28 found in glioblastoma promotes an invasive and angiogenic phenotype.

Soroceanu L, Matlaf L, Bezrookove V, Harkins L, Martinez R, Greene M, Soteropoulos P, Cobbs CS.

Cancer Res. 2011 Nov 1;71(21):6643-53. doi: 10.1158/0008-5472.CAN-11-0744. Epub 2011 Sep 7.

6.

Prevalence of human cytomegalovirus, polyomaviruses, and oncogenic viruses in glioblastoma among Japanese subjects.

Hashida Y, Taniguchi A, Yawata T, Hosokawa S, Murakami M, Hiroi M, Ueba T, Daibata M.

Infect Agent Cancer. 2015 Jan 27;10:3. doi: 10.1186/1750-9378-10-3. eCollection 2015.

7.

Discordant humoral and cellular immune responses to Cytomegalovirus (CMV) in glioblastoma patients whose tumors are positive for CMV.

Rahbar A, Peredo I, Solberg NW, Taher C, Dzabic M, Xu X, Skarman P, Fornara O, Tammik C, Yaiw K, Wilhelmi V, Assinger A, Stragliotto G, Söderberg-Naucler C.

Oncoimmunology. 2015 Feb 25;4(2):e982391. eCollection 2015 Feb.

8.

Cytomegalovirus pp71 protein is expressed in human glioblastoma and promotes pro-angiogenic signaling by activation of stem cell factor.

Matlaf LA, Harkins LE, Bezrookove V, Cobbs CS, Soroceanu L.

PLoS One. 2013 Jul 5;8(7):e68176. doi: 10.1371/journal.pone.0068176. Print 2013.

9.

Cytomegalovirus and brain tumor: epidemiology, biology and therapeutic aspects.

Cobbs CS.

Curr Opin Oncol. 2013 Nov;25(6):682-8. doi: 10.1097/CCO.0000000000000005. Review.

PMID:
24097102
10.

Cytomegalovirus Immediate-Early Proteins Promote Stemness Properties in Glioblastoma.

Soroceanu L, Matlaf L, Khan S, Akhavan A, Singer E, Bezrookove V, Decker S, Ghanny S, Hadaczek P, Bengtsson H, Ohlfest J, Luciani-Torres MG, Harkins L, Perry A, Guo H, Soteropoulos P, Cobbs CS.

Cancer Res. 2015 Aug 1;75(15):3065-76. doi: 10.1158/0008-5472.CAN-14-3307.

11.

Human cytomegalovirus-mediated immunomodulation: Effects on glioblastoma progression.

Foster H, Ulasov IV, Cobbs CS.

Biochim Biophys Acta Rev Cancer. 2017 Aug;1868(1):273-276. doi: 10.1016/j.bbcan.2017.05.006. Epub 2017 May 26. Review.

PMID:
28554666
12.

Sensitive detection of human cytomegalovirus in tumors and peripheral blood of patients diagnosed with glioblastoma.

Mitchell DA, Xie W, Schmittling R, Learn C, Friedman A, McLendon RE, Sampson JH.

Neuro Oncol. 2008 Feb;10(1):10-8. Epub 2007 Oct 19.

13.

Human cytomegalovirus gene expression in long-term infected glioma stem cells.

Fiallos E, Judkins J, Matlaf L, Prichard M, Dittmer D, Cobbs C, Soroceanu L.

PLoS One. 2014 Dec 30;9(12):e116178. doi: 10.1371/journal.pone.0116178. eCollection 2014.

14.

Human cytomegalovirus infection levels in glioblastoma multiforme are of prognostic value for survival.

Rahbar A, Orrego A, Peredo I, Dzabic M, Wolmer-Solberg N, Strååt K, Stragliotto G, Söderberg-Nauclér C.

J Clin Virol. 2013 May;57(1):36-42. doi: 10.1016/j.jcv.2012.12.018. Epub 2013 Feb 4.

PMID:
23391370
15.

Low levels of Human Cytomegalovirus Infection in Glioblastoma multiforme associates with patient survival; -a case-control study.

Rahbar A, Stragliotto G, Orrego A, Peredo I, Taher C, Willems J, Söderberg-Naucler C.

Herpesviridae. 2012 Mar 16;3:3. doi: 10.1186/2042-4280-3-3.

16.

Poor survival in glioblastoma patients is associated with early signs of immunosenescence in the CD4 T-cell compartment after surgery.

Fornara O, Odeberg J, Wolmer Solberg N, Tammik C, Skarman P, Peredo I, Stragliotto G, Rahbar A, Söderberg-Nauclér C.

Oncoimmunology. 2015 Jun 5;4(9):e1036211. eCollection 2015 Sep.

17.

Evolving evidence implicates cytomegalovirus as a promoter of malignant glioma pathogenesis.

Cobbs CS.

Herpesviridae. 2011 Oct 26;2(1):10. doi: 10.1186/2042-4280-2-10.

18.

Analysis of Chemopredictive Assay for Targeting Cancer Stem Cells in Glioblastoma Patients.

Howard CM, Valluri J, Alberico A, Julien T, Mazagri R, Marsh R, Alastair H, Cortese A, Griswold M, Wang W, Denning K, Brown L, Claudio PP.

Transl Oncol. 2017 Apr;10(2):241-254. doi: 10.1016/j.tranon.2017.01.008. Epub 2017 Feb 12.

19.

Progranulin promotes Temozolomide resistance of glioblastoma by orchestrating DNA repair and tumor stemness.

Bandey I, Chiou SH, Huang AP, Tsai JC, Tu PH.

Oncogene. 2015 Apr 2;34(14):1853-64. doi: 10.1038/onc.2014.92. Epub 2014 May 5.

PMID:
24793792
20.

Human cytomegalovirus antigens in malignant gliomas as targets for adoptive cellular therapy.

Landi D, Hegde M, Ahmed N.

Front Oncol. 2014 Nov 26;4:338. doi: 10.3389/fonc.2014.00338. eCollection 2014. Review.

Supplemental Content

Support Center